Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-17-007979
Filing Date
2017-02-16
Accepted
2017-02-16 17:13:09
Documents
1
Period of Report
2017-02-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4048
  Complete submission text file 0001140361-17-007979.txt   5502
Mailing Address C/O AEGLEA BIOTHERAPEUTICS, INC. 901 S. MOPAC EXPRESSWAY, SUITE 250 AUSTIN TX 78746
Business Address
Bruhn Suzanne Louise (Reporting) CIK: 0001517790 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37722 | Film No.: 17618758

Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Issuer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations